1_img1424895986.jpg 2_img1424896008.jpg 3_img1424896028.jpg 4_img1424896053.jpg
ГЛЕДФАРМ ЛТД intro pharmacovigilance logo-img
  • 1-img1423128723_img1424877095.jpg
  • 2-img1423128732_img1424877082.jpg
  • 3-img1423128813_img1424877070.jpg
  • 4-img1423128825_img1424877057.jpg
  • analiz111_img1422534233.jpg

GLUTAZONE tablets

PIOGLITAZONE

Treatment of II type diabetes mellitus:

as monotherapy

  • in patients (especially in obese patients) with contraindications and intolerance to metformin in case of inadequate control or glucose level with diet and exercises;

as double combined therapy with

  • metformin in patients (especially in obese patients) with insufficient glycemic control despite using maximum tolerated dose of metformin;
  • sulfonylurea derivatives only in patients with contraindications and intolerance to metformin in case of insufficient glycemic control despite using maximum tolerated dose of sulfonylurea derivatives;

as triple combined therapy with

  • metformin and sulfonylurea derivatives in patients (especially in obese patients) with insufficient glycemic control despite using double combined therapy.

Glutazone® is also indicated in combination with insulin in patients with II type diabetes mellitus with insufficient glycemic control despite using insulin, who have contraindications or intolerance to metformin.

1 tablet contains pioglitazone hydrochloride equivalent to pioglitazone 15 mg or 30 mg, or 45 mg; Antidiabetic drugs. Hypoglycemic drugs, excluding insulins. Thiazolidinediones.

View instructions Dounload instruction